Zoladex
Colorectal Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)Phase 1/2Active
CC
45/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 40/ 100
- Competitive Position
- 59/ 100
Competitive context
481 Active assets in the Colorectal Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Calcium folinate pentahydrate UNICANCER | Phase 4 | BB |
PANITUMUMAB MSPU des 3 Provinces | Phase 3 | BB |
Levoleucovorin Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Phase 3 | BB |
FLUOROURACILUM UNICANCER | Phase 4 | BB |
Eloxatin Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Phase 4 | BB |
View all 50 →
Same molecule, other indications
Zoladex is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →